Unjoni Ewropea - Malti - EMA (European Medicines Agency)

viatris healthcare limited - imiquimod - condylomata acuminata; keratosis; keratosis, actinic; carcinoma, basal cell - antibijotiċi u kimoterapewtiċi għal użu dermatoloġiku - imiquimod cream is indicated for the topical treatment of :external genital and perianal warts (condylomata acuminata) in adults. small superficial basal cell carcinomas (sbccs) in adults. clinically typical, nonhyperkeratotic, nonhypertrophic actinic keratoses (aks) on the face or scalp in immunocompetent adult patients when size or number of lesions limit the efficacy and/or acceptability of cryotherapy and other topical treatment options are contraindicated or less appropriate.

Unjoni Ewropea - Malti - EMA (European Medicines Agency)

viatris healthcare limited - imiquimod - keratosis; keratosis, actinic - antibijotiċi u kimoterapewtiċi għal użu dermatoloġiku - zyclara huwa indikat għall-trattament topiku ta klinikament tipiku, mhux hyperkeratotic, mhux hypertrophic, viżibbli jew palpable keratosis actinic tal-wiċċ sħiħ jew scalp balding fl-adulti immunokompetenti meta huma għażliet oħra ta ' trattament topiku contraindicated jew inqas xierqa.

Unjoni Ewropea - Malti - EMA (European Medicines Agency)

paion deutschland gmbh - eravacycline - infection; bacterial infections - antibatteriċi għal użu sistemiku, - xerava huwa indikat għall-kura ta ' infezzjonijiet intra-addominali kkumplikati (ciai) fl-adulti. għandha tingħata kunsiderazzjoni għall-gwida uffiċjali dwar l-użu xieraq ta ' sustanzi antibatteriċi.

Unjoni Ewropea - Malti - EMA (European Medicines Agency)

paion deutschland gmbh - l-anġjotensina ii acetate - hypotension; shock - aġenti li jaġixxu fuq is-sistema renin-angiotensin - giapreza huwa indikat għall-kura ta refrattarji pressjoni baxxa fl-adulti bil-settiku jew oħra distribuzzjoni xokk li jibqgħu ipotensivi minkejja l-volum adegwat restituzzjoni u l-applikazzjoni ta'catecholamines u oħra disponibbli terapiji vasopressor.

Unjoni Ewropea - Malti - EMA (European Medicines Agency)

paion deutschland gmbh - remimazolam besilate - sedazzjoni konxja - psikolettiċi - remimazolam is indicated in adults for procedural sedation. remimazolam 50 mg is indicated in adults for intravenous induction and maintenance of general anaesthesia.

Unjoni Ewropea - Malti - EMA (European Medicines Agency)

viatris limited - aflibercept - macular edema; retinal vein occlusion; diabetic retinopathy; myopia, degenerative; diabetes complications - oftalmoloġiċi - yesafili is indicated for adults for the treatment ofneovascular (wet) age-related macular degeneration (amd) (see section 5. 1),visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo) (see section 5. 1),visual impairment due to diabetic macular oedema (dme) (see section 5. 1),visual impairment due to myopic choroidal neovascularisation (myopic cnv) (see section 5.

Unjoni Ewropea - Malti - EMA (European Medicines Agency)

shionogi b.v. - naldemedine tosilate - stitikezza - mediċini għall-istitikezza, periferali opioid ta ' l-antagonisti tar-riċettur - rizmoic huwa indikat għat-trattament ta ' stitikezza ikkaġunata minħabba opjojdi (oic) fil-pazjenti adulti li jkunu diġà ġew ittrattati bl-lassattiv.